Soligenix Announces Successful Protection using a Bivalent Thermostabilized Filovirus Vaccine
/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...